Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sofie Leisby Antonsen

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Acta Obstetricia Et Gynecologica Scandinavica|December 16, 2011
Pass on the knifeSofie Leisby Antonsen, Ida Kirkegaard,
Gynecologic Oncology|December 27, 2011
Patients with atypical hyperplasia of the endometrium should be treated in oncological centersSofie Leisby Antonsen, Lian Ulrich, Claus Høgdall
Ugeskrift for Laeger|January 26, 2011
[Need of better preoperative staging of endometrial cancer]Sofie Leisby Antonsen, Lian Ulrich, Claus K Høgdall
Ugeskrift for Laeger|February 7, 2025
[A woman with a live interstitial pregnancy and previous salpingectomy]Signe Grønborg Thomsen, Carsten Lindberg Fagö-Olsen, Sofie Leisby Antonsen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 6, 2018
Type I Versus Type II Endometrial Cancer: Differential Impact of ComorbidityMette Calundann Noer, Sofie Leisby Antonsen, Bent Ottesen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2017
Ovarian Cancer and Comorbidity: Is Poor Survival Explained by Choice of Primary Treatment or System Delay?Mette Calundann Noer, Cecilie Dyg Sperling, Bent Ottesen, et al.
Gynecologic Oncology|April 9, 2016
A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patientsMette Calundann Noer, Cecilie Dyg Sperling, Sofie Leisby Antonsen, et al.
Acta Oncologica (Stockholm, Sweden)|February 17, 2018
Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients - a comparative cohort studyMette Calundann Noer, Pia Leandersson, Torbjørn Paulsen, et al.
Anticancer Research|February 11, 2014
Biomarkers for predicting complete debulking in ovarian cancer: lessons to be learnedCarsten Lindberg Fagö-Olsen, Bent Ottesen, Ib Jarle Christensen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2014
Differences in regional diagnostic strategies and in intended versus actual first-line treatment of patients with advanced ovarian cancer in DenmarkCarsten Lindberg Fagö-Olsen, Bent Ottesen, Henrik Kehlet, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Acta Obstetricia Et Gynecologica Scandinavica|December 16, 2011
Pass on the knifeSofie Leisby Antonsen, Ida Kirkegaard,
Gynecologic Oncology|December 27, 2011
Patients with atypical hyperplasia of the endometrium should be treated in oncological centersSofie Leisby Antonsen, Lian Ulrich, Claus Høgdall
Ugeskrift for Laeger|January 26, 2011
[Need of better preoperative staging of endometrial cancer]Sofie Leisby Antonsen, Lian Ulrich, Claus K Høgdall
Ugeskrift for Laeger|February 7, 2025
[A woman with a live interstitial pregnancy and previous salpingectomy]Signe Grønborg Thomsen, Carsten Lindberg Fagö-Olsen, Sofie Leisby Antonsen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 6, 2018
Type I Versus Type II Endometrial Cancer: Differential Impact of ComorbidityMette Calundann Noer, Sofie Leisby Antonsen, Bent Ottesen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 13, 2017
Ovarian Cancer and Comorbidity: Is Poor Survival Explained by Choice of Primary Treatment or System Delay?Mette Calundann Noer, Cecilie Dyg Sperling, Bent Ottesen, et al.
Gynecologic Oncology|April 9, 2016
A new clinically applicable age-specific comorbidity index for preoperative risk assessment of ovarian cancer patientsMette Calundann Noer, Cecilie Dyg Sperling, Sofie Leisby Antonsen, et al.
Acta Oncologica (Stockholm, Sweden)|February 17, 2018
Confounders other than comorbidity explain survival differences in Danish and Swedish ovarian cancer patients - a comparative cohort studyMette Calundann Noer, Pia Leandersson, Torbjørn Paulsen, et al.
Anticancer Research|February 11, 2014
Biomarkers for predicting complete debulking in ovarian cancer: lessons to be learnedCarsten Lindberg Fagö-Olsen, Bent Ottesen, Ib Jarle Christensen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|August 8, 2014
Differences in regional diagnostic strategies and in intended versus actual first-line treatment of patients with advanced ovarian cancer in DenmarkCarsten Lindberg Fagö-Olsen, Bent Ottesen, Henrik Kehlet, et al.
Pageof 2